Literature DB >> 17961570

Misoprostol for the termination of pregnancy up to 12 completed weeks of pregnancy.

A Faúndes1, C Fiala, O S Tang, A Velasco.   

Abstract

The aim was to review the current knowledge about the use of misoprostol alone for abortion induction during the first 12 weeks of pregnancy. Publications reporting experiences with misoprostol alone for pregnancy termination within the first 12 weeks of pregnancy were included in the analysis. Vaginal administration of 800 microg repeated up to three times at 6, 12 or 24 h intervals has an 85% to 90% effectiveness, defined as complete abortion, in most studies. Oral administration is less effective, but sublingual administration at 3-hour interval has the same effectiveness, with more frequent side effects. The oral and sublingual routes appear to be better accepted than vaginal administration. Most studies are limited to the first 9 weeks of pregnancy. The experience on pregnancy termination between 10 and 12 weeks is not yet sufficient for a recommendation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17961570     DOI: 10.1016/j.ijgo.2007.09.006

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  10 in total

1.  Perceptions and practices of illegal abortion among urban young adults in the Philippines: a qualitative study.

Authors:  Jessica D Gipson; Alanna E Hirz; Josephine L Avila
Journal:  Stud Fam Plann       Date:  2011-12

2.  Effectiveness of Misoprostol for Induction of First-Trimester Miscarriages: Experience at a single tertiary care centre in Oman.

Authors:  Qamariya Ambusaidi; Anita Zutshi
Journal:  Sultan Qaboos Univ Med J       Date:  2015-11-23

3.  Induced abortions and unintended pregnancies in pakistan.

Authors:  Zeba Sathar; Susheela Singh; Gul Rashida; Zakir Shah; Rehan Niazi
Journal:  Stud Fam Plann       Date:  2014-12

4.  Comprehensive abortion care: evidence of improvements in hospital-level indicators in Tigray, Ethiopia.

Authors:  Ndola Prata; Suzanne Bell; Amanual Gessessew
Journal:  BMJ Open       Date:  2013-07-24       Impact factor: 2.692

5.  Efficacy of intra-cervical misoprostol in the management of early pregnancy failure.

Authors:  Abdulrahim A Rouzi; Nisma Almansouri; Nora Sahly; Nawal Alsenani; Hussam Abed; Khalid Darhouse; Nabil Bondagji
Journal:  Sci Rep       Date:  2014-11-24       Impact factor: 4.379

6.  Misoprostol use in medical evacuation of spontaneous miscarriage: Pilot drug use evaluation study at the Women's Hospital in Qatar.

Authors:  Samah A ElSalem; Doua T AlSaad; Palli V Abdulrouf; Afif A Ahmed; Moza S AlHail
Journal:  Qatar Med J       Date:  2016-06-15

7.  Moving from legality to reality: how medical abortion methods were introduced with implementation science in Zambia.

Authors:  Tamara Fetters; Ghazaleh Samandari; Patrick Djemo; Bellington Vwallika; Stephen Mupeta
Journal:  Reprod Health       Date:  2017-02-16       Impact factor: 3.223

8.  Using a Call Center to Reduce Harm From Self-Administration of Reproductive Health Medicines in Bangladesh: Interrupted Time-Series.

Authors:  Katherine Keenan; Katharine Footman; Munnaf Sadekin; Kate Reiss; Reena Yasmin; Hannah Franklin; Kathryn Church
Journal:  JMIR Public Health Surveill       Date:  2019-08-04

Review 9.  Facility-based treatment for medical complications resulting from unsafe pregnancy termination in the developing world, 2012: a review of evidence from 26 countries.

Authors:  S Singh; I Maddow-Zimet
Journal:  BJOG       Date:  2015-08-19       Impact factor: 6.531

10.  Women's self-reported experiences using misoprostol obtained from drug sellers: a prospective cohort study in Lagos State, Nigeria.

Authors:  Melissa Stillman; Onikepe Owolabi; Adesegun O Fatusi; Akanni I Akinyemi; Amanda L Berry; Temitope P Erinfolami; Olalekan S Olagunju; Heini Väisänen; Akinrinola Bankole
Journal:  BMJ Open       Date:  2020-05-05       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.